PBM Investigations Should Not Overshadow Value Of Industry, Express Scripts Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Despite recent investigations of pharmacy benefit management business practices the industry remains a good model, Express Scripts CEO Barrett Toan said during an earnings call July 29
You may also be interested in...
N.Y. Suit Against Express Scripts Alleges Overcharges For Generic Drugs
The suit focuses on Express Scripts' administration of the New York state employee health plan pharmacy benefit. New York AG alleges that PBM overcharged for generic drugs, "disguised" manufacturer rebates and illegally sold plan data to manufacturers and data collection services.
N.Y. Suit Against Express Scripts Alleges Overcharges For Generic Drugs
The suit focuses on Express Scripts' administration of the New York state employee health plan pharmacy benefit. New York AG alleges that PBM overcharged for generic drugs, "disguised" manufacturer rebates and illegally sold plan data to manufacturers and data collection services.
Medicare Card Enrollment Is Disappointing, Express Scripts Acknowledges
Pharmacy Care Alliance card program has enrolled 110,000 members so far, less than half of Express Scripts break-even goal. Slow uptake of discount cards is factor in downward revision in Express Scripts' earnings forecast, but PBM notes that cards have saved seniors money.